TALPHERA, INC. — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2021-02-06

Reporting Person: Dasu Badri N (Chief Engineering Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-06	Common Stock	F	6846	$2.59	Disposed	151532	Direct

Footnotes

F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

F3: Balance includes acquisition of 1,265 shares of Common Stock through the Company's Employee Stock Purchase Plan and reflects the correction of the overreporting of 541 ESPP shares purchased on August 31, 2016.